Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ICPT > SEC Filings for ICPT > Form 8-K on 19-Dec-2012All Recent SEC Filings

Show all filings for INTERCEPT PHARMACEUTICALS INC

Form 8-K for INTERCEPT PHARMACEUTICALS INC


19-Dec-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On December 19, 2012, Intercept Pharmaceuticals, Inc. issued a press release announcing that it has completed enrollment in POISE, its pivotal Phase 3 clinical trial of obeticholic acid (OCA) in primary biliary cirrhosis (PBC).

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits.

(d) The following exhibit is filed with this report:

Exhibit
Number  Description

99.1    Press Release dated December 19, 2012.

The press release contains hypertext links to information on our website and/or other websites. The information contained in or accessible from our website or any other website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.

  Add ICPT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ICPT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.